MitrAssist
Minimally Invasive Treatment for Mitral Regurgitation
Startup C Health Tech & Life Sciences Est. 2009
Total Raised
$204M
C
Last Round
$100M
5 rounds
Investors
7
7 public
Team
1
1-10 employees
Confidence
89/100
News
7
articles
About
MitrAssist has developed an approach to treating patients with life-threatening mitral regurgitation (MR) that involves neither repair nor replacement. Instead, the companys proprietary valve implant is placed on top of the natural valve to work in unison with it and to enhance valve functionality. MitrAssists valve-in-valve approach overcomes the various challenges of MR and offers an alternative treatment solution for all MR patients. Made from biomedical and biological materials, MitrAssists valve offers improved biocompatibility and patient recovery time.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
cardiologyhospitalsdoctorsbiomaterialssurgerymedical-devicesvalvesminimally-invasive
Funding & Events
Nov 2017
A Round $30M
Fosun Pharma, Ping An Ventures
Jul 2023
C Round $100M
Centurium Capital (Lead), 6 Dimension Capital (Lead)
Jul 2013
Seed $1M
Jan 2014
A Round $3M
LongTec HongTao China Ventures
Dec 2020
B Round $70M
Centurium Capital (Lead), Fosun Pharma, Ping An Ventures, 6 Dimension Capital , CITIC Capital, CICC Capital
News (7)
Sep 27, 2023 · www.dealstreetasia.com
growth-positive
Centurium, 6 Dimensions lead $100m Series C round for medtech startup MitrAssist
InvestmentExpand
Sep 27, 2023 · g-medtech.com
growth-positive
Shanghai MITRASSIST Medical Closes Nearly $100 Million Series C Financing - G-MedTech News Center
InvestmentExpand
Dec 2, 2020 · en.globes.co.il
growth-positive
Israeli medical valve co MitrAssist raises $50m
InvestmentExpand
Nov 9, 2017 · nocamels.com
growth-positive
Heart Valve Company MitrAssist Raises $30M
Investment
Nov 8, 2017 · www.calcalistech.com
growth-positive
Fosun Leads $30 Million Round for Heart Valve Company MitrAssist
InvestmentExpand
Jul 1, 2013 · en.globes.co.il
growth-positive
Heart valve implant co MitrAssist raises $1m
Investment
May 26, 2013 · nocamels.com
growth-positive
Minimally Invasive Treatment May Soon Be Possible For People With Mitral Regurgitation Disorder
Investment
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
3
District
Center District
Founded
2009
Registrar
514263789
Crunchbase
mitrassist
Locations
Alon Hatavor 20, Caesarea, Israel
Links
Website
LinkedIn
Admin
Last Update
Sep 14, 2024
Verified by
Sharon Shapira
Missing
video or image, markets, not claimed
Team (1)
Gil Naor
Founder & CEO
Founder
Internal
Created by
Arielle Smolin (ari.smolin@gmail.com)
Created
2014-07-20T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)